Kosh Agarwal

机构：King's College - North Carolina, King's College Hospital NHS Foundation Trust, King's College Hospital · ORCID：0000-0002-4754-828X

发表论文 635 篇 · 总被引 23157 次 · h-index 59

代表论文

• Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection (2026 · New England Journal of Medicine · 被引 23)
• A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D (2025 · New England Journal of Medicine · 被引 16)
• Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells (2025 · Journal of Hepatology · 被引 13)
• ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 5)
• Prediction of Hepatocellular Carcinoma and Other Liver‐Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 · Alimentary Pharmacology & Therapeutics · 被引 5)
• Bulevirtide for chronic hepatitis delta: from clinical trials to real life data: an expert opinion report (2025 · Antiviral Research · 被引 4)